Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: Contribution of the androgen receptor polyglutamine tract polymorphism

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 9, 2007, Pages 3604-3610

  Crabbe, P ^a   Bogaert, V ^a   De Bacquer, D ^a   Goemaere, S ^a   Zmierczak, H ^a   Kaufman, Jean Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; LUTEINIZING HORMONE; POLYGLUTAMINE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXON; FEEDBACK SYSTEM; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SENSITIVITY ANALYSIS; TESTOSTERONE BLOOD LEVEL;

EID: 34548742493     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0117     Document Type: Article

References (35)

1. Vermeulen A, Kaufman JM, Giagulli VA 1996 Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81:1821-1826
2. Ukkola O, Gagnon J, Rankinen T, Thompson PA, Hong Y, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C 2001 Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 145:1-9
3. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833-876
4. Meikle AW, Stringham JD, Bishop DT, West DW 1988 Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J Clin Endocrinol Metab 67:104-109
5. Ring HZ, Lessov CN, Reed T, Marcus R, Holloway L, Swan GE, Carmelli D 2005 Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin Endocrinol Metab 90:3653-3658
6. Kaufman JM, T'Sjoen GG, Vermeulen A 2006 Androgens in male senescence. In: Nieschlag E, Behre HM, eds. Testosterone, action, deficiency, substitution. Cambridge, UK: Cambridge University Press; 497-541
7. Vermeulen A, Verdonck G 1992 Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 74:939-942
8. Andersson AM, Carlsen E, Petersen JH, Skakkebaek NE 2003 Variation in levels of serum inhibin B, testosterone, estradiol, luteinizing hormone, follicle-stimulating hormone, and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons. J Clin Endocrinol Metab 88:932-937
9. Chamberlain NL, Driver ED, Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
10. Albertelli MA, Scheller A, Brogley M, Robins DM 2006 Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20:1248-1260
11. Mifsud A, Sim CKS, Boettger-Tong H, Moreira S, Lamb DJ, Lipshultz LI, Yong EL 2001 Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril 75:275-281
12. Zitzmann M, Nieschlag E 2003 The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26:76-83
13. Mifsud A, Choon AT, Fang D, Yong EL 2001 Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men. Mol Hum Reprod 7:1007-1013
14. Walsh S, Zmuda JM, Cauley JA, Shea PR, Metter EJ, Hurley BF, Ferrell RE, Roth SM 2005 Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol 98:132-137
15. Coetsier P, De Backer G, De Corte W 1996 Etude belge du stress au travail: aperçu du modèle de recherche et des outils d'investigation. Psychologie Psychométrie 17:17-35
16. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
17. Van Uytfanghe K, Stockl D, Kaufman JM, Fiers T, De Leenheer A, Thienpont LM 2005 Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Biochem 38:253-261
18. Aiman J, Griffin JE, Gazak JM, Wilson JD, MacDonald PC 1979 Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med 300:223-227
19. Hayes FJ, Seminara SB, DeCruz S, Boepple PA, Crowley Jr WF 2000 Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 85:3027-3035.
20. Raven G, de Jong FH, Kaufman JM, de Ronde W 2006 In men, peripheral estradiol levels directly reflect the action of estrogens at the hypothalamo-pituitary level to inhibit gonadotropin secretion. J Clin Endocrinol Metab 91:3324-3328
21. Veldhuis JD, King JC, Urban RJ, Rogol AD, Evans WS, Kolp LA, Johnson ML 1987 Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 65:929-941
22. Choong CS, Kemppainen JA, Zhou ZX, Wilson EM 1996 Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10:1527-1535
23. Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA, Tilley WD 2004 Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet 13:1677-1692
24. Hiort O, Holterhus PM, Horter T, Schulze W, Kremke B, Bals-Pratsch M, Sinnecker GHG, Kruse K 2000 Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab 85:2810-2815
25. Harkonen K, Huhtaniemi I, Makinen J, Hubler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pollanen P 2003 The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26:187-194
26. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E 2003 Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 88:2049-2054
27. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF 1996 Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81:4400-4405
28. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C 2000 Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60:5111-5116
29. Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW 1999 Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162:137-142
30. Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C, Kaufman JM 2001 Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf) 55:659-666
31. Canale D, Caglieresi C, Moschini C, Liberati CD, Macchia E, Pinchera A, Martino E 2005 Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol (Oxf) 63:356-361
32. Liu PY, Death AK, Handelsman DJ 2003 Androgens and cardiovascular disease. Endocr Rev 24:313-340
33. Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A, Nieschlag E 2001 The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867-4873
34. Hersberger M, Muntwyler J, Funke H, Marti-Jaun J, Schulte H, Assmann G, Luscher TF, von Eckardstein A 2005 The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem 51:1110-1115
35. Page ST, Kupelian V, Bremner WJ, McKinlay JB 2006 The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65:333-339